CoFactor (ANX-510)

DRUG2 trials

Sponsors

Mast Therapeutics, Inc.

Conditions

Breast CancerColon CancerMetastatic Colorectal CancerRectal Cancer

Phase 2

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

Mast Therapeutics, Inc.Breast Cancer

Start: 2006-02-28Target: 31Updated: 2008-04-22

Phase 3

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Mast Therapeutics, Inc.Colon Cancer, Metastatic Colorectal Cancer, Rectal Cancer

Start: 2006-05-31Target: 1200Updated: 2007-11-19